CliffBio

AUCTA

Patent cliffs & loss of exclusivity

Founded in Berlin in 2019 by Elias Alonso, Henri Huselstein and Daniel Seiler, AUCTA was a CAD and 3D visualization software company that sold the AUCTA Player and Manager. AUCTA GmbH entered liquidation in January 2026.

Company

Company Operating StatusClosed
Crunchbase URLhttps://www.crunchbase.com/organization/aucta
Email format{first}
Full AddressZionskirchstraße 15, Berlin, Berlin 10119, DE
LinkedIn URLhttps://www.linkedin.com/company/aucta/
Official NameAucta
Pitchbook URLhttps://pitchbook.com/profiles/company/437714-74
Seedtable URLhttps://seedtable.com/companies/aucta

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. MOTPOLY XRLACOSAMIDESmall mol.Jun 2040
  2. MOTPOLY XRLACOSAMIDESmall mol.Jun 2040
  3. MOTPOLY XRLACOSAMIDESmall mol.Jun 2040
  4. FOSFOMYCIN TROMETHAMINEFOSFOMYCIN TROMETHAMINESmall mol.—
  5. VIGADRONEVIGABATRINSmall mol.—
  6. DEFERASIROXDEFERASIROXSmall mol.—
  7. DEFERASIROXDEFERASIROXSmall mol.—
  8. DEFERASIROXDEFERASIROXSmall mol.—
  9. ZELVYSIASAPROPTERIN DIHYDROCHLORIDESmall mol.—
  10. ZELVYSIASAPROPTERIN DIHYDROCHLORIDESmall mol.—
  11. ARFORMOTEROL TARTRATEARFORMOTEROL TARTRATESmall mol.—
  12. OXCARBAZEPINEOXCARBAZEPINESmall mol.—
  13. PYQUVIDEFLAZACORTSmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.